Cargando…

Cardiac Tissue Engineering for the Treatment of Myocardial Infarction

Poor cell engraftment rate is one of the primary factors limiting the effectiveness of cell transfer therapy for cardiac repair. Recent studies have shown that the combination of cell-based therapy and tissue engineering technology can improve stem cell engraftment and promote the therapeutic effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Dongmin, Wang, Xiaowei, Ye, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617685/ https://www.ncbi.nlm.nih.gov/pubmed/34821706 http://dx.doi.org/10.3390/jcdd8110153

Ejemplares similares

Injectable cardiac tissue engineering for the treatment of myocardial infarction
por: Wang, Haibin, et al.
Publicado: (2010)

Macrophage Polarization in Cardiac Tissue Repair Following Myocardial Infarction
por: Kim, Yevgeniy, et al.
Publicado: (2021)

Injectable Hydrogels for Cardiac Tissue Repair after Myocardial Infarction
por: Hasan, Anwarul, et al.
Publicado: (2015)

hESCs‐Derived Early Vascular Cell Spheroids for Cardiac Tissue Vascular Engineering and Myocardial Infarction Treatment
por: Liu, Yang, et al.
Publicado: (2022)

Recent Advances in Cardiac Tissue Engineering for the Management of Myocardium Infarction
por: Sharma, Vineeta, et al.
Publicado: (2021)

Novel Therapies for the Treatment of Cardiac Fibrosis Following Myocardial Infarction
por: Raziyeva, Kamila, et al.
Publicado: (2022)

Cardiac troponin and defining myocardial infarction
por: Kaier, Thomas E, et al.
Publicado: (2021)

The effect of immune cell‐derived exosomes in the cardiac tissue repair after myocardial infarction: Molecular mechanisms and pre‐clinical evidence
por: Wen, Heling, et al.
Publicado: (2021)

Cardiac monocytes and macrophages after myocardial infarction
por: Peet, Claire, et al.
Publicado: (2020)

Cardiac biomarkers and detection methods for myocardial infarction
por: Kim, Sang Young, et al.
Publicado: (2022)

Noninvasive Assessment of an Engineered Bioactive Graft in Myocardial Infarction: Impact on Cardiac Function and Scar Healing
por: Gálvez‐Montón, Carolina, et al.
Publicado: (2016)

Estrogen Receptors: Therapeutic Perspectives for the Treatment of Cardiac Dysfunction after Myocardial Infarction
por: da Silva, Jaqueline S., et al.
Publicado: (2021)

Non-Viral Gene Delivery Systems for Treatment of Myocardial Infarction: Targeting Strategies and Cardiac Cell Modulation
por: Wang, Jieting, et al.
Publicado: (2021)

The cardiac wound healing response to myocardial infarction
por: Chalise, Upendra, et al.
Publicado: (2022)

Engineering Extracellular Matrix Proteins to Enhance Cardiac Regeneration After Myocardial Infarction
por: Esmaeili, Hamid, et al.
Publicado: (2021)

Local activation of cardiac stem cells for post-myocardial infarction cardiac repair
por: Wen, Zhuzhi, et al.
Publicado: (2012)

Advances in the study of exosomes derived from mesenchymal stem cells and cardiac cells for the treatment of myocardial infarction
por: Liu, Yuchang, et al.
Publicado: (2023)

Role of Irisin in Myocardial Infarction, Heart Failure, and Cardiac Hypertrophy
por: Ho, Ming-Yun, et al.
Publicado: (2021)

The Inflammatory Response and Cardiac Repair After Myocardial Infarction
por: Nah, Deuk-Young, et al.
Publicado: (2009)

Cardiac troponins: from myocardial infarction to chronic disease
por: Park, Kyung Chan, et al.
Publicado: (2017)

Molecular imaging of cardiac remodelling after myocardial infarction
por: Curley, Daniel, et al.
Publicado: (2018)

Nanomaterials for Cardiac Tissue Engineering
por: R. Amin, Devang, et al.
Publicado: (2020)

Advances in Cardiac Tissue Engineering
por: Kitsuka, Takahiro, et al.
Publicado: (2022)

The Efficacy and Safety of Bisoprolol in the Treatment of Myocardial Infarction with Cardiac Insufficiency
por: Wang, Yan
Publicado: (2022)

Modified mRNA as a Treatment for Myocardial Infarction
por: Wang, Yu, et al.
Publicado: (2023)

Noncoding RNAs in Cardiac Autophagy following Myocardial Infarction
por: Turkieh, Annie, et al.
Publicado: (2019)

Pharmacological Modulation of Cardiac Remodeling after Myocardial Infarction
por: Zhao, Wei, et al.
Publicado: (2020)

Cardiac cAMP-PKA Signaling Compartmentalization in Myocardial Infarction
por: Colombe, Anne-Sophie, et al.
Publicado: (2021)

Role of Neutrophils in Cardiac Injury and Repair Following Myocardial Infarction
por: Ma, Yonggang
Publicado: (2021)

Cardiac fibrosis in myocardial infarction—from repair and remodeling to regeneration
por: Talman, Virpi, et al.
Publicado: (2016)

Cardiac metabolism as a driver and therapeutic target of myocardial infarction
por: Zuurbier, Coert J., et al.
Publicado: (2020)

Nuclear Molecular Imaging of Cardiac Remodeling after Myocardial Infarction
por: Varasteh, Zohreh, et al.
Publicado: (2022)

Crosstalk between macrophages and cardiac cells after myocardial infarction
por: Jian, Yuhong, et al.
Publicado: (2023)

Cardiac macrophages and emerging roles for their metabolism after myocardial infarction
por: Thorp, Edward B.
Publicado: (2023)

Possible Treatment of Myocardial Infarct Based on Tissue Engineering Using a Cellularized Solid Collagen Scaffold Functionalized with Arg-Glyc-Asp (RGD) Peptide
por: Schussler, Olivier, et al.
Publicado: (2021)

Prospect of 3D bioprinting over cardiac cell therapy and conventional tissue engineering in the treatment of COVID-19 patients with myocardial injury
por: Akter, Fariya, et al.
Publicado: (2021)

3D bioprinting in cardiac tissue engineering
por: Wang, Zihan, et al.
Publicado: (2021)

Engineering and Assessing Cardiac Tissue Complexity
por: Tadevosyan, Karine, et al.
Publicado: (2021)

Nanomaterials for Cardiac Myocyte Tissue Engineering
por: Amezcua, Rodolfo, et al.
Publicado: (2016)

Artificial Scaffolds in Cardiac Tissue Engineering
por: Roacho-Pérez, Jorge A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lvgcqfb80hnuifavaml8mhmcl1